John Vissing Selected Research

Phosphoglucomutase

1/2018	Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency.
7/2013	Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Vissing Research Topics

Disease

31	Glycogen Storage Disease Type V (McArdle's Disease) 01/2022 - 05/2002
29	Muscular Diseases (Myopathy) 01/2021 - 03/2009
16	Muscular Dystrophies (Muscular Dystrophy) 05/2022 - 05/2002
15	Mitochondrial Myopathies (Mitochondrial Myopathy) 04/2021 - 05/2002
13	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2020 - 03/2012
11	Glycogen Storage Disease (Glycogenosis) 01/2020 - 06/2002
10	Myasthenia Gravis 06/2022 - 03/2014
9	Glycogen Storage Disease Type II (Pompe's Disease) 05/2022 - 11/2012
9	Myalgia 01/2022 - 10/2002
9	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 10/2003
8	Muscle Weakness 05/2021 - 02/2010
8	Limb-girdle muscular dystrophy type 2A 01/2020 - 08/2008
7	Myoglobinuria 09/2021 - 10/2002
6	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2017 - 11/2008
5	Fatigue 06/2022 - 12/2012
5	Disease Progression 12/2021 - 03/2007
5	Type 2I Limb-Girdle Muscular Dystrophy 01/2020 - 08/2008
4	Neuromuscular Diseases (Neuromuscular Disease) 12/2021 - 12/2018
4	Oculopharyngeal Muscular Dystrophy 08/2020 - 04/2011
4	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2018 - 07/2003
3	Muscular Atrophy (Muscle Atrophy) 01/2022 - 01/2013
3	Hypoxia (Hypoxemia) 01/2021 - 05/2012
3	Ophthalmoplegia (External Ophthalmoplegia) 01/2020 - 04/2008
3	Sarcoglycanopathies 01/2020 - 04/2015
3	Insulin Resistance 07/2019 - 06/2002
3	X-Linked Bulbo-Spinal Atrophy 01/2019 - 03/2016
3	Glycogen Storage Disease XIV 01/2018 - 07/2013
3	Hearing Loss (Hearing Impairment) 09/2014 - 12/2006
3	Muscle Cramp (Cramp) 03/2009 - 01/2005
2	Myotonic Dystrophy (Dystrophia Myotonica) 01/2022 - 10/2012
2	VLCAD deficiency 01/2022 - 08/2004
2	Acidosis 12/2021 - 12/2012
2	Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic) 01/2021 - 10/2020
2	Headache (Headaches) 01/2021 - 12/2017
2	Inclusion Body Myositis 01/2021 - 01/2019
2	Deglutition Disorders (Dysphagia) 08/2020 - 01/2017
2	Vacuolar myopathy 10/2019 - 07/2013
2	Heart Failure 06/2019 - 12/2018
2	Multiple Acyl Coenzyme A Dehydrogenase Deficiency 03/2019 - 09/2017
2	Fibrosis (Cirrhosis) 01/2019 - 12/2015
2	Contracture 01/2019 - 11/2017
2	Bethlem myopathy 01/2019 - 01/2018
2	Rhabdomyolysis 01/2019 - 01/2016
2	Atrophy 01/2018 - 01/2014

Drug/Important Bio-Agent (IBA)

25	GlycogenIBA 05/2022 - 06/2002
20	Mitochondrial DNA (mtDNA)IBA 12/2021 - 07/2003
17	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2002
17	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2011
14	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 08/2002
11	Creatine Kinase (Creatine Phosphokinase)IBA 11/2020 - 06/2006
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2016
7	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 12/2021 - 05/2009
7	Oxygen (Dioxygen)IBA 06/2017 - 05/2002
6	glucose-mannose-glucoseIBA 06/2022 - 01/2016
6	EnzymesIBA 10/2019 - 06/2006
6	CarbohydratesIBA 09/2017 - 03/2009
5	GlucosidasesIBA 05/2022 - 07/2013
5	Muscle Form Glycogen Phosphorylase (Myophosphorylase)IBA 01/2018 - 09/2002
4	Cholinergic ReceptorsIBA 05/2021 - 12/2017
4	CalpainIBA 01/2020 - 03/2012
3	AcidsIBA 05/2022 - 11/2012
3	Carnitine palmitoyl transferase 2 deficiencyIBA 01/2022 - 10/2002
3	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022 - 09/2017
3	AnoctaminsIBA 12/2021 - 08/2013
3	MyostatinIBA 01/2021 - 01/2013
3	bimagrumabIBA 01/2021 - 01/2019
3	eculizumab FDA Link 07/2020 - 12/2017
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2014
3	CalciumIBA 01/2020 - 12/2012
3	Insulin (Novolin)FDA Link 07/2019 - 06/2002
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 10/2002
3	Sucrose (Saccharose)IBA 09/2017 - 12/2003
3	Nonesterified Fatty Acids (NEFA)IBA 10/2014 - 01/2004
3	LipidsIBA 04/2012 - 09/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2014
2	TransferasesIBA 01/2022 - 01/2018
2	Long-Chain Acyl-CoA Dehydrogenase (Long-Chain-Acyl-Coenzyme A Dehydrogenase)IBA 01/2022 - 08/2004
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2004
2	polyglucosanIBA 01/2021 - 10/2017
2	Monoclonal AntibodiesIBA 01/2021 - 01/2019
2	IsotopesIBA 05/2020 - 08/2004
2	Phosphorylases (Glucan Phosphorylase)IBA 01/2020 - 09/2005
2	Contractile ProteinsIBA 01/2020 - 01/2016
2	Coenzyme A (CoA)IBA 12/2019 - 06/2006
2	Oxidoreductases (Dehydrogenase)IBA 12/2019 - 06/2006
2	triheptanoinIBA 10/2019 - 09/2017
2	TropomyosinIBA 06/2019 - 04/2014
2	Dynamin IIIBA 06/2019 - 06/2012
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2019 - 01/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 12/2018
2	CollagenIBA 01/2019 - 01/2018
2	human GAA protein (Myozyme)FDA Link 01/2019 - 05/2014
2	Sarcoglycans (beta Sarcoglycan)IBA 01/2018 - 04/2015
2	PhosphoglucomutaseIBA 01/2018 - 07/2013
2	AmmoniaIBA 11/2017 - 08/2002

Therapy/Procedure

12	Therapeutics 01/2020 - 06/2006
6	Enzyme Replacement Therapy 05/2022 - 07/2013
3	Activities of Daily Living (ADL) 01/2021 - 12/2017
3	Resistance Training 01/2018 - 02/2013
2	Exercise Therapy (Therapy, Exercise) 12/2019 - 03/2016